Juvena Therapeutics

Juvena Therapeutics is a biopharmaceutical company founded in 2017 with its headquarters in the United States. The company focuses on decoding secreted proteins to address chronic and age-related diseases. Its recent milestone was the $41.00M Series A investment secured on 08 November 2022. The notable investors in this funding round include Felicis Ventures, Horizons Ventures, Plum Alley Investments, Alumni Ventures Blockchain Fund, BoxOne Ventures, Transform VC, Intersect VC, Irongrey, Karl Pfleger, and Jeff Dean. Juvena Therapeutics aims to leverage this investment to advance its research and development efforts and further its impact in the biopharma, biotechnology, and healthcare industries. With a strong investor lineup and a promising focus on decoding secreted proteins, Juvena Therapeutics is positioned for growth and innovation in the coming years.